Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for DHR and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for DHR and 80,000+ other tickers.
See exactly how DHR's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DHR and 80,000+ other tickers.
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics…
Life sciences company Danaher said on Wednesday it plans to launch its first AI-powered autonomous research lab early next year to make drug discovery and development faster and more efficient.
Helping researchers to move from discovery to breakthrough up to 8x faster by combining AI, automation and innovation from across Danaher's ecosystem of industry-leading technologies WASHINGTON, Oct. 7, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced plans to launch its first AI-powered autonomous lab, designed to help researchers develop custom antibodies and other molecular tools faster and more efficiently. Expected to operate at scale in early 2027, the lab will combine artificial intelligence, robotics and technologies from several Danaher operating companies in one connected workflow.
Park National Corp OH increased its holdings in Danaher Corporation (NYSE: DHR) by 6.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 90,107 shares of the conglomerate's stock after buying an additional 5,678 shares during the quarter. Park
Rockland Trust Co. raised its position in Danaher Corporation (NYSE: DHR) by 1,318.0% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 94,026 shares of the conglomerate's stock after buying an additional 87,395 shares during the quarter. Rockland Trust Co.'s holdings in Danaher were worth $20,831,000
Eastover Investment Advisors LLC bought a new stake in Danaher Corporation (NYSE: DHR) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,185 shares of the conglomerate's stock, valued at approximately $1,149,000. A number of other hedge funds have also recently